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In pursuing work on the classical third component of human complement, a 
heretofore unrecorded  serum protein has been detected and recognized as an 
essential factor in the later steps of immune hemolysis (1). The purpose of this 
paper is to describe the procedure of its isolation, some of its molecular proper- 
ties,  and to define the position at which this protein acts in the complement-re- 
action sequence. On the basis of immunoelectrophoretic characteristics, it has 
been designated/31rglobulin and in reference to its activity, the fifth component 
of human complement or C'5. 
The existence of/31F-globulin was first discovered by means of antisera pre- 
pared to/31c-globulin isolated according to a  method described previously (2). 
While these/310 preparations seemed immunologically homogeneous when ana- 
lyzed with powerful anfisem to whole human serum, they nevertheless gave rise 
to antibodies to 2 minor contaminants when injected into rabbits;  1 of which 
was/31~-globulin. The detection of these contaminants necessitated reinvestiga- 
tion of the role of/31c-globulin in immune hemolysis (3). In the course of this 
analysis, it was found that the activity previously attributed solely to/3xc-globu- 
lin is, in fact, the result of at least 3 factors, 1 of which is/3at-globulin, the other 
/3aF-globulin,  and the 3rd is a  factor which is still not recognized as a  discrete 
protein entity (4). In terms of their activity, these 3 factors will be referred to in 
the following as the third, fifth, and sixth components of complement, or C'3, 
C'5, and C'6. 
Materials and Methods 
Serum and Serum Fractions.--Freshly  drawn blood from white donors was purchased from 
the San Diego Blood Bank, San Diego. Mtera period of 4 hours at room temperature, during 
which clotting was allowed to proceed, the serum, approximately 400 ml, was pooled and 
dialyzed for 18 hours at 4°C against 2 X  10 liters of phosphate buffer, pH 5.4, T/2 =  0.02. 
In order to prevent conversion of/3xc to/31A, EDTA in a final concentration of 0.005  rr 
was added to the individual sera prior to pooling. By dialysis the EDTA concentration was 
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allowed to decrease to 0.0002 g  and was maintained at this level until the material was sub- 
jected to TEAE-cellulose chromatography. 
The eugiobulin formed during dialysis was separated from the rest of the serum by cen- 
trifugation at 1560 g and 2°C for 20 minutes. The precipitate was washed 3 times with 750 
ml of dialysis buffer and dissolved in 20 ml of phosphate buffer, pH 8.1, 2"/2  =  0.03.  Some 
NaC1 in substance was added to facilitate solution of the protein. The dissolved euglobulins 
were separated from lipid material by centrifugation for 1 hour at 20,000 ~M., in a  Spineo 
model L2  ultracentrifuge, using a  No.  40 rotor.  A  dear,  faintly yellow-green solution was 
collected through a hole punched into the bottom of the centrifuge tube. The top layer con- 
taining the rotated lipid material was discarded. The eugiobulin was dialyzed for 6 to 8 hours 
against several changes of starting buffer prior to chromatography. 
TEAE Ckromatography.--Approximately  300 ml of packed TEAE-cellulose in a  2.5 X  60 
cm column was equilibrated with phosphate buffer, pH 8.1,  T/2,  --  0.03  (starting buffer). 
After the euglobulin was applied, the column was washed with 700 to 900 ml of starting buffer, 
and elution was then begun by applying a  gradient of increasing salt concentration and de- 
creasing pH. An open cone sphere system was used which consisted of a  1000 ml round flask 
filled  with starting buffer and a  500 ml Erlenmeyer flask containing 0.25 x, monobasic Na 
phosphate. Elution was completed with 200 to 300 ml of 0.25 ,~ monobasio phosphate. Frac- 
tions containing 31c- and 31F-globulin were concentrated by precipitation in phosphate buffer, 
pH 5.4,  T/2  =  0.02. 
Hydroxyl Apatite Chromatography.--Oil  apatite chromatography was performed according 
to the procedure described by Tiselius el o2. (5). Buffers were prepared by combining suitable 
proportions of 0.02 g  Na-phosphate with 0.65 ~  KNa-phosphate buffer of pH 7.9. The 0.65 
KNa-phosphate buffer was obtained by mixing 0.65 g  dibasic potassium phosphate with 
0.65 M monobasic sodium phosphate. The different buffers were defined by their conductance 
at 23°C.  Starting buffer had a conductance of 8  mmhos/cm. Approximately 100 ml of packed 
OH apatite in a  2.5  X  20 cm column were equilibrated with starting buffer. The material 
obtained by TEAE-cellulose chromatography was then applied to the columu without pre- 
ceding dialysis. After washing of the column with 300 ml of starting buffer, stepwise elution 
was begun. The conductance of the buffers employed was 12,  13, and 14.5 mmhos/cm, respec- 
tively. The column was reused after washing with 0.65 ~  KNa-phosphate buffer. 
Fractions containing 310 were pooled and the protein was precipitated by dialysis against 
phosphate buffer, pH 5.4,  T/2  =  0.02.  The precipitate was dissolved in a  small volume of 
phosphate buffer, pH 7, T/2 =  0.1 and NaC1 was added to facilitate its solution. 
Preparative Electrophoresis.--Fractions  containing 3a~ after OH  apatite chromatography 
were pooled and concentrated by ultrafiltration. The material was then separated by prepara- 
tive electrophoresis in Pevikon blocks, as previously described (6). The separation was carried 
out at 4°C, in barbital buffer, pH 8.6, T/2  =  0.05 for 35 hours employing a potential gradient 
of 3.5 v/cm. 
Starch Gel Electrophoresis.--Starch  gel electrophoresis was performed according to Smithies 
(7)  using the discontinuous buffer system of Poulik (8). A  filter paper  carrier was used for 
application of the samples. Electrophoresis was carried out at 4°C for 12 hours at  5 v/era. In 
certain instances protein was eluted with veronal buffer from the unstained half of the gel by 
freezing and thawing of suitable segments and used for further analysis. 
Ultracentrlfugation.--Sedimentation  coefficients were  determined  in  a  Spinco  model  E 
ultracentrifuge at  20°C.  Phosphate buffer, pH  7, T/2  =  0.1 was used as  solvent. Density 
gradient ultracentrifugation was carried out according to Kunkel (9). 
A ntisera.-- 
Anti-fllF:  Antibodies to fl~  globulin were obtained by immunizing rabbits with purified 
~lF-globulin or with fractions containing fllF- and 31c-globulin. 3 X  1 mg of protein was given IYLF R.  NILSSON  AND  ttANS  J.  ]~ULLER-EBER.HARD  279 
subcutaneously in complete Freund's adjuvant in weekly intervals. Three weeks after the 
last injection the animals were bled. 
Antisera prepared to a  mixture of/31o and/3at were rendered specific for/31r-giobulin by 
adsorption with purified/31o. 
Anti-/310: Specific  antisera to 81o were obtained by immunizing rabbits with purified/310- 
globulin or with zymosan treated with human serum according to a procedure published else- 
where (10). 
Anti-/31z: Rabbit antisera to/31m were prepared by immunization with purified/3m-globulin, 
as described earlier (11). 
Other antisera: Autisera to the following human serum proteins were purchased from Beh- 
ringwerke AG.,  West Germany: No. 470E, normal serum; No.  240L, ~/A-giobulin; No.  65, 
"yG-globulin; No. 329A, transferrin; No. 440C,/3-1ipoprotein; No. 444F, fibrinogen. In addi- 
tion, a horse anti--'rM-giobulin was used (No. 477D). 
Immunodiffusion  techniques: Immunoelectrophoresis was performed according to Scheideg- 
ger (12). Immunologic analysis of highly purified/3w-giobulin was done on Ouchterlony plates. 
Localization and semiquantitation of/31F in fractions obtained by chromatography, electro- 
phoresis, or zone ultracentrifugation was carried out on microscopic slides, covered with an 
agar layer and  containing a  central longitudinal row  of  11  wells  and longitudinal lateral 
troughs. The wells were filled with test fractions and the troughs with antisera. 
Diluents, chdating, and bacteriostatic agents: Veronal buffered  saline cont~inlng Ca  ++ and 
Mg  ++ (13), with or without 0.1 per cent gelatin (w/v), was used  as  diluent for  complement 
assays. 0.1 x  sodium-ethylenediaminetetraaceticacid (EDTA) solution, pH 7.6, was prepared 
by mixing 7.44 gm Na2 EDTA with 7.60 gm Na+ EDTA in a volume made up to 400 ml with 
distilled  H20. 
It was noted that bacterial growth sometimes occurred in the chromatography columns, 
leading to a partial conversion of/3xc to a product similar to/3xx. This complication was avoided 
by introducing chloramphenicol as a  bacteriostatic agent. A  concentration of 5  X  10  -5 
was present throughout the separation procedures (0.8 ml of a 2 per cent solution of chloram- 
pbenicol in 95 per cent ethanol (w/v) was added per liter of buffer). The high optical density 
at 280 m/z caused by this concentration of chloramphenicol made OD 280 readings less reliable 
for protein determinations than the Folin method. Therefore, the latter method was employed 
in most instances. 
Preparation of Complexes Consisting of Erythrocytes, Antibody, and Complement.-- 
EAC~la,4,ga:  Cells in the state EAC'la,4,2a were prepared according to the following 
procedure. A flask containing 7.5 X  109 sensitized sheep erythrocytes in 15 ml veronal buffer 
was warmed to 37°C.  In a second flask 150 mg phloridzin was dissolved in 15 ml veronal buffer 
by heating to approximately 80°C.  Subsequently the temperature was adjusted to 37°C.  After 
the contents of the 2 flasks were mixed, 0.75 ml fresh human serum was added. The mixture 
was incubated for 2 minutes at 37°C, and was then poured into ice cold gelatin containing 
veronal buffer. The cells were washed 2 times and resuspended in 15 ml geiatin-veronal buffer, 
and kept at 0--1°C until used. 
EAC'la,4,ga,3:10 s EAC'la,4,2a cells were treated with 10 #g  of purified /31c-giobulin 
for 2.5 minutes at 30°C in a  volume of 0.5 ml containing 0.01 ~  EDTA. The cells were then 
washed and resuspended to a suitable volume in ice cold gelatin-veronal buffer. 
EAC'la,4,ga,3,5,6:  These cells were prepared by incubating 10  s EAC'la, 4,2a cells for 20 
minutes at 37°C in a 0.5 ml volume containing 0.01 ~x EDTA, 10 #g/3xc, 20/.tg ~IF and a suf- 
ficient amount of partially purified C'6. The cells were washed and stored in gelatin-veronal 
buffer. 
C'5 assay: 10  s EAC'ta,4,2a  0.05 ml 0.1 ~s EDTA, 10 #g/3it, and a sufficient amount of C'6 
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termined separately for each new batch of C~6 using the R6 assay (see below). The volume of 
the test system was adjusted to 0.45 ml. The reaction mixture was then held at 37°C for 20 
minutes before addition of 0.05 ml human serum. After 20 minutes, 2  ml cold saline were 
added and the samples were centrifuged to remove unlysed cells.  The degree  of  lysls  was 
determined spectrophotometrically at 541 m/~. 
In some instances, CI5 activity was estimated by utilizing the ability of C'5 to reconstitute 
a  sublytic dose of human serum. ~ll~-globulin was reacted with l0  s EAC'la,4,2a cells in the 
presence of 0.05 ml human serum diluted 1:30 and 0.05 ml 0.1 ~r EDTA. The reaction volume 
was 0.5 ml. Lysis was allowed to proceed for 20 minutes at 37°C, and the degree of lysis was 
determined spectrophotometrically at 541 m#. 
Kinetic analysis of the formation of EA C'la, 4 ,2a,3,5 ,6: EAC'la, 4,2a,3 cells were reacted 
with C'5 and C'6, added simultaneously or in sequence of varying order. One ml of reaction 
mixture contained 2.2 X  l0  s cells, 20/zg/3ic, 40 #g/3tr, C'6, and EDTA in a final concentration 
of 0.011 ~. The temperature was 30°C. Samples of 0.45 ml containing 10  s cells were withdrawn 
at timed intervals, transferred to 6 volumes of ice cold gelatin-veronal buffer, and centrifuged 
for 5 minutes at 4°C, whereupon the supernatants were discarded. The cells were resuspended 
in 0.45 ml gelatin-veronal buffer containing 0.011 ~  EDTA. Upon completion of sampling, all 
samples were incubated at  37°C  for 20 minutes.  Thereafter,  each sample received 0.05  ml 
human serum and was incubated for an additional 10 minutes. 
Assay of C'6 using complement-deficient rabbit serum: Serum  from  complement-deficient 
rabbits was shown to lack C'6 (14). Since it can be reconstituted fully with human C'6, such 
serum was used as a reagent for the assay of C'6. Two methods were used:  (a)  An aliquot of 
the test sample was allowed to react with 2.5 X  107 sensitized sheep cells and 0.15 ml of a 1 : 15 
dilution of complement-deficient rabbit serum. The reaction volume was adjusted to 0.3 ml. 
Incubation at 32°C varied from 45 to 75 minutes in different experiments. Lysis was terminated 
by the addition of 1.5 ml cold saline followed by centrifugation. The degree of hemolysis was 
determined spectrophotometrically at  415  m/~. (b)  EAC'la,4,2a,3  cells were prepared by 
incubating 2  X  109  sensitized sheep erythrocytes with 0.2 ml complement-deficient  rabbit 
serum  in  10  ml  of  gelatin-veronal  buffer.  After  30  minutes'  incubation  at  32°C,  40 
ml ice cold gelatin-veronal buffer was added. The cells were washed twice and resuspended in 
8  ml  gelatin-veronal  buffer.  2.5  X  107  EAC'la,4,2a,3  cells  were  set  up  with  0.15 
ml complement-deficient rabbit serum diluted  1:15, test samples for C'6 determination and 
EDTA in a  final concentration of 0.01 ~.  The reaction volume was 0.3 ml. After 45 to 75 
minutes at 32°C  1.5  ml cold saline  was added,  the tubes  were centrifuged and lysls  was 
determined at 415 m#. 
Agglutination tests: A specific antiserum to/31r was heat-inactivated and diluted in twofold 
steps from 1:5 to 1:320. One drop of diluted antiserum, 1 drop of a  1 per cent suspension of 
EAC'la,4,2a,3,5,6  cells,  and 1 drop of saline were mixed on a  sfide.  After 10 minutes, ag- 
glutination was evaluated macroscopicaUy. 
RESULTS 
Requirement of Several Serum Factors for the Conversion  of EA C'  la, 4,2a,  to a 
Thermostable Intermediate Complex.--Preparations  of/31c-globulin, isolated ac- 
cording to a  previously described method  (2), have been shown to be effective 
in converting the thermolabile intermediate complex EAC'la,4,2a  to a  thermo- 
stable state  (3). Injection of such ~1c preparations into rabbits resulted in the 
production of antisera which contained antibodies to/31c-globulin, but, also, to 
2 other serum proteins. Fig.  1 shows an immunoelectrophoretic pattern of the 3 
proteins in the euglobulin fraction of human  serum.  The  2  proteins which mi- ULF  R.  NILSSON  AND  HANS  J.  Mf3LLER-EBERHARD  281 
grate faster than Sic-globulin are designated/~xr- and ~m-globulin, respectively. 
Small amounts of these 2 proteins were consistently found  to  contaminate/31c 
globulin prepared by the earlier method. 
Correlating activity and protein distribution after  electrophoresis of this ma- 
Fie. 1. Immunoelectrophoretic demonstration of antibodies to 2 additional serum proteins 
(/31F and/~IH) in antiserum prepared to/~le-globulin isolated according to the original method. 
Analysis was performed on human euglobulin; the anode was on the right. 
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FIG.  2.  Comparative  electrophoretic  analysis  of EACqa,4,2a  stabilizing  activity,  /~le- 
and/~l~-globulin. The distribution  of the activity correlates neither with/31c nor with  /~IF. 
Electrophoresis was performed on ~le-globulin (prepared according to the original method) 
on a  Pevikon block in phosphate  buffer pH 7.0, T/2  =  0.1. Origin is indicated  by arrow; 
the anode was at the right. Distribution  of/~lC and ~IF was estimated immunologically. 
terial on a Pevikon block at pH 7.0 showed the activity to be slightly faster than 
the protein peak (Fig. 2). Immunologic analysis of the block fractions indicated 
partial separation of/~IF and/~1c and revealed that the mobility of the activity 
was intermediate to that of the 2 proteins. This suggested that the activity is not 
resident in either protein, or that it results from the action of both components. 282  ISOLATION  OF  ~IF-GLOBULIN 
In the latter case, complete separation of Blc and  BJF should be accompanied by 
loss of activity and  recombination  of the separated  proteins  should  lead  to its 
reconstitution.  That this hypothesis was probably correct was suggested by the 
finding that combination of fractions 8 and  11  (Fig. 2), which, per se, contained 
little activity, gave rise to potentiation  of their activity rather than to an addi- 
tive effect. 
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FIC. 3.  Comparative electrophoretic  analysis  of purified  ~le-  and  /3iF-globulin and  of 
partially purified C'6. Electrophoresis of the 3 samples was carried out simultaneously  on the 
same Pevikon block for 33 hours in barbital buffer pH 8.6, T/2 =  0.05 and a potential gradi- 
ent of 3.5  v/cm. Origin was at segment  1. ~le and fltF represented  as protein  (Folin),  C'6 
as activity. 
After separation and purification  of/31c- and ~tF-globulin had been achieved 
with procedures to be described below, it became apparent that these 2 proteins 
were insufficient  to convert EAC'la,4,2a  cells to a  thermostable  intermediate 
state.  In the course of their purification,  a  third  factor became separated  from 
the 2 proteins which, as was found  later,  is also required  for the  conversion of 
EAC'la,4,2a  cells.  This  third  factor is not identical  with tim; at pH 8.6 it is 
electrophoretically slower than/3to, although it overlaps to some extent with it. 
A  precipitating  antibody  to  this  component,  which  is  called  C'6,  has  not ULF  R.  NILSSON  AND  HANS  J.  MULLER-EBERHARD  283 
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Fio.  4.  Detection of EAC'la,4,2a  stabilizing activity  (C'3,  C'5,  and C'6)  in euglobulin 
fractions after chromatography on TEAE-cellulose. Gradient was started at tube 80. By im- 
munologic analysis, /~1c and/~w were detected in fractions 140 through 180.  Fractions  140 
through 160 were pooled and concentrated for further separation on hydroxyl apatite. 
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FI6.  5.  Chromatographic separation of /~lc- and /~lFglobulin on hydroxyl  apatite.  The 
protein (fractions 140 to 160, Fig. 4) was applied in PO4 buffer adjusted to a  conductance of 8 
mmhos/cm. It was eluted stepwise by buffers of increasing PO4 concentration. The arrows in- 
dicate change of buffer, and the bars the distribution of ~lC  and ~IF as  estimated  immuno- 
logically.  Fractions 70 to 90 were pooled and concentrated for further separation by zone 
electrophoresis. 284  ISOLATION  OF  ~IF-GLOBULIN 
been found to date in spite of several attempts  to produce anti-C'6 antibodies 
in rabbits by injecting partially purified preparations.  Identification of C'6 with 
an individual  serum protein has not yet been achieved. However, work on its 
final purification and characterization is in progress. 
Fig.  3  demonstrates  the  electrophoretic  patterns  of  the  3  components  re- 
quired for the conversion of EAC'la,4,2a to a  thermostable state hereafter de- 
scribed as EAC'la, 4,2a, 3,5,6. ~ic or C'3 and 31v or C'5 are represented as pro- 
teins,  C'6 as activity. The necessity of C'3, C'5, and  C'6 for the conversion of 
EAC'la,4,2a  to  a  thermostable  complex  follows from  the  observation  that 
omission of any one of the 3 factors from the reaction mixture results in failure 
to produce a  thermostable complex (see below). 
TABLE I 
Purification of l31F 
1.  Preparation  of euglobulin 
2.  TEAE chromatography 
3.  OH apatite chromatography 
4.  Preparative  electrophoresis 
Precipitated  from  fresh  human  serum  dl- 
alysed  against  PO4  buffer,  pH  5.4, 
T/2  =  0.02. 
PO4  buffer  gradient  elution  (0.03  M,  pH 
8.1 -* 0.25 M NaHzPO4). 
PO.I buffer, pH  7.9, stepwlse elution  (con- 
ductance: 8, 12, 13, and 14.5 m-mhos). 
Pevikon  block, barbital  buffer,  pH  8.6, 
T/2  =  0.05. 
Isolation of Blv-Globulin.--Since  ~lv is a  euglobulin, like 131c, this fraction of 
serum was used  as starting material.  Chromatography of the euglobulin frac- 
tion on TEAE-cellulose allowed the separation of/31F  from most proteins  pres- 
ent except/31c  and ¢51H. The 3 proteins were eluted  together in a  pH  range  of 
6.8 to 6.0. Although C'6 activity was, in part, eluted with earlier fractions, con- 
siderable amounts of this  component overlapped  with/31v and J51c, thus giving 
rise to complete EAC'la,4,2a stabilizing activity in fractions 140 to 180 of the 
chromatogram shown in Fig. 4. 
To separate all 3 proteins from each other and to obtain C'6-free fl~F and ~Jc 
chromatography on hydroxyl apatite  was used.  A  stepwise  elution procedure 
was  worked  out  employing increasing  salt  concentration  at  pH  7.9  (Fig.  5). 
According to this method, f51F is eluted at a conductance of 12 mmhos/cm, ~IH 
and  C'6 at a  conductance of 13 mmhos/cm. The bulk of the ~1c is eluted in a 
final step at a conductance of 14.5 mmhos/cm. There is trailing of 3m-globulin 
but not of C'6 into the ~c eluates so that only the second half of this step con- 
tains pure/31c-globulin. 
Concentrated fractions of 31v obtained by OH apatite  chromatography con- ULF  R.  NILSSON  AND  HANS  J.  M/JLLER-EBERHARD  285 
tain less  than  10 per cent contaminants,  as estimated  by preparative  electro- 
phoresis  and  sucrose  density grandient ultracentrifugation.  Traces of ")'a- and 
a2-globulins  can  be  shown  by  immunoelectrophoresis.  In  order  to  eliminate 
FIG. 6. Immunoelectrophoresis of highly purified fllF-globulin. For comparison, the patte rn 
of whole human serum is also shown. Top trough:  rabbit  anti-whole human serum. Middle 
trough: empty. Bottom  trough: rabbit  anti-/~JF-globulin. Anode was on the right. 
FIG. 7. Schlieren patterns  of isolated/3it-globulin  photographed  at different times during 
ultracentrifugation  at 52,640 RPM: (a) 11 mg/ml, and (b) 6 mg/ml. Note tendency to spreading 
and asymmetry of boundaries. 
these last impurities, the hydroxyl apatite purified/~IF was subjected to prepara- 
tive  electrophoresis  using Pevikon  as supporting medium and barbital  buffer, 
pH 8.6, T/2  =  0.05. After 35 hours at  3.5 v/cm,/~lF-globulin could be eluted 
from the block in highly purified form. Table I summarizes the entire procedure 
of isolation. 
Partially  purified  C'6  was  obtained  by  TEAE  chromatography  of  the 
euglobulins.  It was eluted from the column between pH 7.4 and 6.8 preceding 
elution  of/31c, /31F, and/3m.  Immunologic analysis of partially purified  C'6 re- 
vealed the presence of 3'G- and of 3,A-globulin but of no other major serum pro- 
tein that can be detected with an antiserum to whole human serum. 
Some Properties of ~lF-Globulin.--Purified  ~lF-globulin was tested by Ouchter- ]2 
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lony's double diffusion technique against a variety of antisera. A single precipi- 
tin line was formed with an antiserum to whole human serum and with specific 
anti-31F serum. The 2 lines fused completely with each other, showing a reaction 
of identity.  Negative reactions were obtained with antisera prepared to 3'A-, 
3,M-, 7G-globulin, transferrin, fllc-, 3m-globulin, fibrinogen, and fS-lipoprotein. 
The  preparations  were  homogeneous also  by immunoelectrophoretic  criteria. 
Fig. 6 demonstrates the position of the/31F precipitin line in relation to the pat- 
tern of whole human serum. Using an anti-whole human serum, ~1F could not be 
detected in human serum. This is due to the low serum concentration of/3~ as 
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FIG.  8. S versus  C plot for ~lF-globulin, showing an anomalous concentration dependence of 
the s-rate. By least-square analysis, y  =  0.33 x  +8.7. 
well as to insufficient amounts of tilt antibody in antiserum against whole hu- 
man serum. Analysis of aged fllF preparations (stored at +  4°C for 1 month or 
more) revealed immunologic and electrophoretic heterogeneity. Part of the pro- 
tein was converted to a faster migrating component which showed partial im- 
munologic identity with native fllF-globulin. The nature of this product awaits 
further studies. 
Ultracentrifugal analysis of 3 different preparations at various concentrations 
disclosed a single boundary in each instance, precluding the presence of a readily 
detectable contaminant. There was, however, a marked tendency to boundary 
spreading and to boundary asymmetry, as can be seen in Fig. 7. Comparing the 
schlieren patterns of the same preparation at 2 different protein concentrations, 
it is apparent that at higher concentration the peak of the boundary is shifted 
toward the bottom and at lower concentration toward the top of the cell.  This 
phenornenon  indicates a  tendency  of the  ~IF molecules to interact with  each 
other and  to form polymers at  higher protein concentration.  The anomalous 
concentration dependence of the s-rate is depicted in Fig. 8. The slope of the s UL]?  R.  NILSSON  AND  HANS  J.  MULLER-EBERHARD  287 
vs. c plot is -[-0.33 and the sedimentation coefficient at infinite dilution, s°20,w = 
8.7S. 
Comparison  of  Physicochemical  Properties  of  ~xr-Globulin  and  of  C'5.-- 
Throughout the procedure of isolation a close correlation was found to exist be- 
tween the distribution of/31F-globulin and of C'5 activity. Although this sup- 
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Flo.  9.  Correlation between the distribution of  C'5 hemolytic activity and /~lr-globulin 
upon ultracentrifugation in a  sucrose density gradient. Note correspondence between major 
protein peak, immunologically estimated/3iv-globulin and C'5 activity. For comparison, the 
pattern of "yG-globulin (Cohn fraction II) is shown. Sedimentation is toward the left. 
ported the hypothesis of their identity, the possibility could not be ruled out 
entirely that the activity was due to a contaminant present in/31r preparations. 
In order to test whether C'5 activity could be dissociated from/31F,  separation 
techniques were employed which differed from those used in the isolation pro- 
cedure. Fig.  9 demonstrates the results obtained when a  /31F preparation ob- 
tained by OH apatite chromatography was subjected to zone ultracentrifuga- 
tion. The position of the ~1F peak is identical to that of C'5 activity. 
Starch gel electrophoresis also failed to separate C'5 and ~IF (Fig.  10). The 
material used in this experiment was prepared by TEAE chromatography and 288  ISOLATION  OF  ~IF-GLOBULIN 
electrophoresis  omitting  OH  apatite  chromatography.  It  contained  a  small 
amount of ~1A, which is visible on the stained gel as a band in front of fizz. Thus, 
all separation procedures employed failed to dissociate C'5 activity and 13jF-glob- 
ulin. 
Characterization of C'5 Activity.--Requirement  of C'5  for the  conversion of 
EAC'la,4, 2a  cells  to a  thermostable  state  is demonstrated  in Table  II. This 
table lists the design and the results of experiments performed  to determine the 
position of C'5 in the complement reaction  sequence.  EAC'la, 4,2a  cells were 
FI6.  10. Correlation between the distribution  of Ct5 hemolytic activity and/3w-globulin 
upon starch gel electrophoresis. Ct5 activity and immunologically demonstrable/3iF-globulin 
occupy the same position in the gel as the major protein band. The faster migrating band was 
caused by contaminating  ~lA-globulln (see text).  Origin at segment 1. After electrophoresis, 
the gel was sliced into 2 halves, one was stained for protein,  the other was cut into suitable 
segments which were eluted and analyzed for C'5 and/51v. 
first treated with  1 or a  combination of 2 of the 3 stabilizing factors,  C'3, C'5, 
and C'6. Thereafter,  the cells were washed, resuspended, and held at 37°C for a 
sufficient period of time to allow decay of non-stabilized cells. During this sec- 
ond period of incubation, the cells were exposed to those factors which were not 
present in the reaction mixture during the first period of treatment. The propor- 
tion of thermostable  intermediate  complexes was  then  determined  by  the de- 
gree of b,sis  ensuing upon addition  of EDTA serum.  Two conclusions can be 
drawn from these results.  A  thermostable intermediate  complex is formed only 
if C'3, C'5~ and C'6 are added together to EAC'la,4, 2a cells~ or if C'5 and C'6 R.  IWILSSON  AND  HANS  J.  MOLLER-~BEP.HARD  289 
are  reacted  with  EAC'la,4, 2a,3  cells.  Secondly, regarding  the  sequence of 
action of the 3 complement factors, it is apparent that C'3 precedes C'5 and 
C'6 and that C'3 is the only one capable of reacting directly with EAC'la, 4,2a 
cells. 
C'5 and C'6 appear to be functionally dependent upon each other, since an 
intermediate complex containing C'5, but not C'6, could not be prepared. How- 
ever, kinetic analysis of the interaction of C'5 and C'6 with EAC'la,4,2a,3 
cells (Fig. 11) indicated that previous incubation of C'5 with the cell complex 
facilitated the subsequent reaction with C'6. Since reversal of the sequence of 
TABLE II 
Determination of the Sequence of Action of C'3, C'5, C'6 on EAC'la, 4, 2a Cells 
First treatment  Second treatment* 
Lysis'with 
EDTA'serum 
5 mln. at 30"C in presence of  20 rain. at 37°C in presence of 
C'3 d- C'5 
C'3 q- C'6 
C'5 Jr C'6 
C'3 
C'5 
C'6 
C'3 -b C'5 -I- C'6 
C'6 
C'5 
C'3 
C'5 q- C'6 
C'3 +  C'6 
C'3 +  C'5 
C'3 @ C'5 -[- C'6 
No 
No 
No 
Yes 
No 
No 
Yes 
Yes 
* Cells were washed between first and second treatment. 
addition resulted in a  lag of onset of EAC'la,2a,3,5,6 formation, tilt-globulin 
was considered to precede functionally C'6 and was therefore designated C'5. 
It will be seen below that this definition of sequence of action may be somewhat 
artificial in view of the tendency of the 2 components to occur in the form of a 
complex in free solution. 
C'5 activity is further characterized by a pronounced thermolability. Incu- 
bation of purified C'5 for 10 minutes at 56°C resulted in 90 per cent inactiva- 
tion. A similar thermolability was not observed with C'6. 
Quanfitation of C'5 activity was performed in 2 systems; one measuring sta- 
bilization of EAC'la,4,2a cells at 37°C in the presence of C'3 and partially puri- 
fied C'6; the other determining lysis of EAC'la, 4,2a cells in the presence of an 
amount of EDTA serum, per se insufficient to cause lysis. The 2 dose-response 
curves obtained are shown in Fig. 12. In both systems, relatively large amounts 
of purified tilt-globulin (C'5) were required to achieve a  significant degree of 
lysis, which is in contrast to the effectiveness of less purified preparations. The 290  ISOLATION 0]?  ~IF-GLOBULIN 
possibility exists,  therefore, that part of the protein became inactivated in the 
course of the long purification procedure or that a cofactor was removed in the 
process, which exerts an enhancing effect on C'3, C'5, or C'6. The possibility of a 
missing cofactor is suggested by the observation that glycine in a concentration 
of 0.05 ~r increases the stabilizing activity of C'3, C'5, and C'6 by 60 per cent. 
Addition of the ultrafiltrate of fresh human serum or the supernatant of boiled 
serum did not result in a similar enhancement of EAC'la, 4,2a stabilization. 
E54I 
0.1~'5 - 
IEAC'I423  +C'5--'] +CI6 
-ooo  -o  f 
I.l.I  //.-  0.050 - 
.o 
E 
~_ 0.025- 
i 
Minutes  of  :50 °  C 
FIG.  11.  Kinetic  analysis  of the  formation  of  the  EACqa,4,2a,3,5,6  complex from 
EAC'la,4,2a,3 cells and C~5 and C~6. The order of addition of the 2 components was varied 
to determine their sequence of action. The open circles represent values obtained on a reaction 
mixture  which initially  contained  EACqa,4,2a,3  cells and C'5.  Mter 3 minutes,  C~6 was 
added  and immediately  thereafter  sampling was begun. The solid circles represent  values 
obtained on EACtla,4,2a,3 initially incubated  with  C'6, whereupon C'5 was added to the 
reaction mixture. The arrow indicates the time of addition of C'5 and C% respectively. Each 
sample withdrawn contained 108 cells, which had reacted with  15 #g fllF and an active dose 
of C"6. 100 per cent lysis corresponds to OD 541 =  0.260. 
While the effect of C'3, C'5, and C% on EAC'la,4, 2a has been described as 
stabilization,  it is not known which moiety of this cell-complement complex is 
actually affected. Since EAC'la, 4, 2a cells tend to revert to the EAC'la, 4 state, 
it was conceivable that C'3, C'5, and C'6 would act by preventing dissociation 
of C'2a. In this case, C'2a should remain associated with the stabilized complex 
(EAC'la,4,2a,3,5,6).  Alternatively,  C'3, C'5, and  C'6 convert EAC'la,4,2a 
cells to a  state in which interaction  with subsequent  complement components 
does no longer depend upon the presence of C'2a. To distinguish between the 2 
possibilities,  various  intermediate  complexes  were  tested  for  their  ability  to UI2 R, NILSSON AND HANS J,  M~LER-EB~RD  291 
convert O~c-globulin to/3~o-globulln. This reaction has previously been shown to 
be catalyzed by cell bound C'2a (15). It was found that cells that have reacted 
with C'3, C'5, and C'6 and that are stable with respect to the effect of subse- 
quent components, are unable to convert ~c-globulln. This experiment shows 
that EAC'la,4,2a cells, after their stabilization by C'3, C'5, and C'6, may be 
devoid of C'2a activity. Thus, C'3, C'5, and C'6 do not seem to act by stabilizing 
C'2a activity. 
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FIo.  12. Dose response curves obtained with purified/3m-globulin. C'5 hemolytic activity 
was measured by two different hemolytic assays:  (A) the dilute serum system; (B) the EAC' 
la,4,2a stabilizing system (in the presence of appropriate amounts of C'3 and  C'6). Lysis of 
108 cells correspond  to OD~ax =  0.260.  65 per cent of the ceils used for these assays were 
in the EAC'la,4,2a state. 
Pkysicoc~mical Interaction between ~lr-Globulin (C'5) and C'6.--Considering 
the s-rates of C'3, C'5, and C'6, which are 9.5, 8.7, and 5S, respectively, EAC  t- 
la,4,2a  stabilizing  activity should be found after density gradient ultracen- 
trffugation somewhere in the 9.5 to 5S region, provided the 3 factors do overlap. 
Contrary to this assumption,  stabilizing  activity was located to a zone sedi- 
menting slightly faster than C'3. This finding suggested the occurrence of pro- 
tein-protein interaction between at least 2 of the 3 factors concerned,  resulting 
in the formation of a faster sedimenting complex. Subsequent analysis revealed 
a tendency of C'6 to complex with C'5, but not with C'3. As demonstrated in 
Fig. 13, partially purified  C'6 sedimented as a single component in the absence 292  ISOLATION  01  ~ fllF-GLOBULrN 
of C'5. However, upon addition of C'5, C'6 activity distributed bimodally, with 
one activity peak corresponding to the original  material and  the other sedi- 
menting more rapidly. Since the fast C'6 component sedimented together with 
C'5, it is concluded that it is present in the form of a complex with C'5, and that 
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FIo.  13. Influence of 31wglobulin (C'5) on the sedimentation behavior of C'6 upon zone 
ultracentrifugation. Bottom pattern represents partially purified C'6, without flw, and the 
top pattern an identical amount of the same preparation of C'6 to which purified flw was 
added. UltracentrEugation was carried out at 35,000 ~  for 18 hours in a  l0 to 40 per cent 
sucrose density gradient prepared in phosphate buffer pH 7.0,  T/2 =  0.1. fllF-Globulin (C'5) 
of top graph is represented by protein. Direction of sedimentation is toward the left. ULF  R.  NILSSON  AND  HANS  J.  MULLER-EBERHARD  293 
slow C'6 represents free material. In experiments where the amount of C'6 was 
diminished  or  the  amount  of  C'5  increased  only  the  fast  sedimenting  C'6 
activity  peak  was  observed.  The  complex  persisted  in  the  presence  of 
0.01 M EDTA. Detection of C'6 activity was facilitated in these experiments 
by the use of complement-deficient rabbit serum which was found to lack C'6 
but none of the other complement components (14). 
To preclude the possibility that the observed interaction resulted from partial 
denaturation of either of the 2 components, fresh human serum was examined 
for the occurrence of a  similar complex. In 2 different sera tested, the major 
portion of C'6 activity sedimented with an s-rate similar to that of the C'5-C'6 
complex. 
TABLE HI 
Uptake of I131-Labeled  ~ar-Globulin (C'5) by Various  Intermediate Corn ,lexes 
Intermediate complex  Complement factors  Amount of  Uptake of 
Experiment  (1.5 X  l0  s cells)  present  #iF I TM  fltF I  TM 
IA* 
B 
IIA~ 
B 
EAC'la,4,2a 
EAC'la,4,2a 
EAC'la,4,2a,3 
EAC'la,4 
C~3, C'5, C'6 
C'3, C'5 (56°C), C'6 
C'5, C'6 
C'5, C'6 
CPM 
228,000 
228,000 
17,850 
17,850 
.'lP~  per ¢enl 
672  0.3 
".316  1.0 
820  4.6 
760  4.3 
* EAC'la,4,2a cells were reacted for 30 minutes at 37°C (A) with hemolytically active 
/3~-globulin and  (B) with heat-inactivated/3~-globulin (56°C for 10 minutes). In A, all 
available EACtla,4,2a cells (41 per cent of the total cell population) were converted to 
EAC'la,4,2a,3,5,6, in B less than 5 per cent. Specific  radioactivity was 4700 cP~a/~g/3m. 
Specific radioactivity was 1490 cPx~/#g/3~. 
Immunoelectrophoretic Analysis of Bar Following Various Treatments of Serum. 
--Immunoelectrophoresis disclosed a  complete disappearance of the tar pre- 
cipitin line after incubation of serum for 1 hour at 56°C. Treatment with zymo- 
san (2.5 mg/ml), or with a bovine albumin-rabbit anti-bovine albumin precipi- 
tate for 2 hours at 37°C, led to diminution, but not to disappearance of the line. 
Dilute hydrazine (0.016 ~) which has previously been shown to alter the im- 
munoelectrophoretic  pattern of 0m- and of 0it-globulin (11, 16) had no apparent 
effect on Bar. 
Analysis of Complement  Treated Immune Complexes for Oar-Globulin.--Since 
certain complement components were shown previously to enter into physical 
union with immune complexes, the question arose as to whether 0ar-globulin 
exhibits a similar behavior. Uptake of Oar by antigen-antibody complexes was, 
indeed, suggested by the diminution of the On, precipitin line, as detected by 
immunoelectrophoresis following  treatment  of  serum  with  antigen-antibody 
complexes or zymosan. To test this hypothesis cells in the stage EAC'la,4, 2a, 294  ISOLATION  OF  ~IF-GLOBULIN 
3,5,6 were carefully washed and reacted with a  series of dilutions of a  specific 
antiserum to flw. No agglutination was detectable. Further, in no experiment 
where EAC'la,4,2a, 3,5,6 cells were prepared with Ira-labeled flJF could any 
uptake significantly higher than that of the controls be demonstrated (Table 
III). Similar results were obtained when an antigen-antibody precipitate (bo- 
vine serum albumin-rabbit anti-bovine serum albumin) was tested which had 
been treated with human serum. After careful washing the precipitate was dis- 
solved by addition of an excess of the antigen, and analyzed in an Ouchterlony 
plate prepared from agar containing 35 rag bovine serum albumin per ml. Al- 
though an antiserum specific for fl~c demonstrated uptake of this complement 
component, no precipitin line was formed with the specific anti-fllF-antiserum. 
DISCUSSION 
The complexity of the classical third component of hemolytic complement has 
been known for some time (17, 18). Linscott and Nishioka (19) demonstrated 
4 subcomponents, whereas Wellensiek and Klein (20) found 5 and Nelson and 
coworkers  (21)  6  factors.  The  classical  third  component  acts,  according 
to Mayer (13),  on the EAC'la,4,2a complex, which, in the course of this re- 
action, is converted to E*. In this state the cell undergoes spontaneous lysis. 
One of the characteristics of the EAC'la,4,2a cell  is its lability at 37°C (13). 
As Mayer (22,  23) has shown, C'2 dissociates from the complex and the cells 
revert  to the EACqa,4 state.  Somewhere midway during the conversion of 
EAC'la,4,2a cells to E*, the cells assume thermostability. In this intermediate 
state they can be held at 37°C for prolonged periods without undergoing spon- 
taneous lysis and without losing susceptibility to the lyric action of subsequent 
complement factors. The thermostable intermediate complex is a  convenient 
tool for the investigator, as it permits division of the reaction of the classical 
third component into two major phases. The first phase leads to the formation 
of a stable complex from EAC'la,4,2a cells the second phase to the conver- 
sion of the stable complex to  E*. The present study is concerned only with the 
first phase of the reaction. 
Originally it was thought that a single protein, tic-globulin, was responsible 
for conversion of EACqa,4,2a cells to a stable complex (3).  Later, 2 compo- 
nents were recognized as essential in this reaction, in human serum ~1c- and ~IF- 
globulin (1), and in guinea pig serum C'3c and C'3b (20). In this paper a third 
factor was pointed out to participate in the stabilization reaction. With refer- 
ence to their activity, these 3 components of human serum have been desig- 
nated C'3, C'5, and C'6 (4, 23, 24). It is emphasized that C'3 denotes the ac- 
tivity of tic-globulin and no longer that of the classical third component of 
complement. 
The chief purpose of this paper was to report a method of isolation of fl~r- 
globulln and to present evidence indicating that this protein is a component of R.  NILSSON  AND  HANS  J.  M~LLER-EB]~RD  295 
the hemolytic complement system. The complement component activity of 
fll~-globulin is primarily manifested in the requirement of this protein for the 
conversion of EAC'la, 4, 2a cells to the stable complex EAC'la, 4, 2a, 3,5,6. In 
a  large  number of experiments  it became  evident that a  stable intermediate 
complex could not be prepared from EAC'la,4,2a cells unless fliF-globulin was 
present in the reaction mixture. The relatively low efficiency of j51F-globulln in 
the stabilizing system, however,  suggests  that a cofactor might be missing or 
that the protein was partially inactivated  during isolation.  This question  is 
presently under investigation. 
Other observations,  not reported in this paper, also support the view that 
fl~-globulin is a component of complement. The serum of certain strains of mice 
have been found to lack hemolytic complement activity (25) as well as one of 
the 13-globulins (26, 27). The defect was shown to be under genetic control (28). 
The deficient murine serum protein designated MuB1 (27) was postulated to be 
a complement component.  Its absence in complement deficient mice is consid- 
ered to be the cause for the apparent complement deficiency. Since Terry et al. 
(29) found the first, second and fourth component intact, the defect could only 
involve one of the later reacting complement  components.  Using mouse anti- 
MuB1 and mouse anti-human fl~, it was possible  to demonstrate a  specific 
immunologic relation between MuB1 and human fllF (30). Thus, MuB1 appears 
to be the murine analogue to fllF, the fifth component of human complement. 
Regarding the mode of action of flxFglobulin, the following tentative con- 
clusions can be drawn, fllF participates in immune hemolysis  without being 
physically incorporated into the cell-complement complex. This behavior sug- 
gests that fllF  plays a mediating role in the complement reaction which is similar 
to that of an enzyme. As the kinetic data indicated,/31F is capable of interacting 
with EAC'la, 4,2a, 3 cells. However, the cells do not seem to be affected by this 
interaction, since an EAC'la, 4,2a, 3,5 complex could not be isolated from the 
reaction mixture. Instead, it appears  that EAC'la,4,2a,3 cells act on fllF con- 
ditioning this protein for its subsequent effect on the cells, which, however, en- 
sues only after addition of C'6. 
In view of the dependence of the/51F effect upon C'6, it was thought probable 
that both factors form a complex in the fluid phase before interacting with cells. 
A fl~FC'6 complex could indeed be demonstrated in solutions containing both 
components in purified form. Evidence was also obtained for the occurrence of a 
similar complex in fresh human serum. This finding, in addition to the kinetic 
data and the failure to prepare EAC'  la, 4,2a, 3,5 cells, suggest that formation 
of the fllF-C'6 complex is a prerequisite for the function of the fifth and the sixth 
component of complement. 
The result of the interaction of C'5,6 with EAC'la,4,2a,3 cells is the stable 
complex symbolized by the expression EAC'la,  4,2a, 3,5,6. The term "stable 
complex" is actually a misnomer. It refers to the lability of the C'2a moiety of 296  ISOLATION OF ~Iy-GLOBULIN 
EAC'la, 4, 2a cells and implies stabilization of this component. Stabilization of 
C'2a is apparently not effected by C'5,6. If it were, EAC'la,4,2a,3,5,6 cells 
should retain the ability to convert/31c-globulin. This, however, was not ob- 
served. It is therefore tempting to speculate that C'5,6 instead of stabilizing 
EAC'la,4,2a,3  exert a  direct effect on the surface of these cells rendering it 
irreversibly susceptible to the action of the terminal components. 
SUMMARY 
At least 3 complement factors were found necessary for the conversion of the 
thermolabile intermediate complex EAC'la,4,2a to a thermostable state. One 
of these factors is the earlier described/31e-globulin. The second, a  heretofore 
unrecorded serum protein, fllF-globulin. The third factor has not yet been de- 
fined as a  discrete serum protein entity. Kinetic experiments indicated  that 
/31c reacted prior to/31r, which in turn seemed to precede the third factor in the 
reaction sequence. Therefore, the 3 components were tentatively designated the 
third (C'3), the fifth (C'5), and the sixth (C'6) components of complement, re- 
spectively. A procedure was developed allowing the isolation of highly purified 
/~1c- (C'3) and/31F-globulin (C'5) and of partially purified C'6. 
With respect to its function in immune hemolysis,/31rglobulin or C'5 was 
found to be closely dependent on the simultaneous presence of C'6.  The hy- 
pothesis that C'5 and C'6 form a functional unit was supported by the finding 
that both components interact with each other in solution resulting in the for- 
marion of a complex. A similar complex was also found in fresh human serum. 
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